메뉴 건너뛰기




Volumn 107, Issue 43, 2010, Pages 18605-18610

Roles and interactions among protease-activated receptors and P2ry12 in hemostasis and thrombosis

Author keywords

Acute coronary syndromes; Myocardial infarction; SCH530348; Stroke; Vorapaxar

Indexed keywords

ADENOSINE DIPHOSPHATE; CLOPIDOGREL; FERRIC CHLORIDE; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; PURINERGIC P2Y12 RECEPTOR; THROMBIN; THROMBIN RECEPTOR ANTAGONIST;

EID: 78649857680     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1013309107     Document Type: Article
Times cited : (42)

References (26)
  • 1
    • 0013118587 scopus 로고    scopus 로고
    • Platelet signal transduction
    • 5th ed.; Coleman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, Eds. (J. B. Lippincott, Philadelphia)
    • Abrams CS, Brass LF (2006) Platelet signal transduction. In Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 5th ed.; Coleman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, Eds. (J. B. Lippincott, Philadelphia) pp 617-629.
    • (2006) Hemostasis and Thrombosis: Basic Principles and Clinical Practice , pp. 617-629
    • Abrams, C.S.1    Brass, L.F.2
  • 2
    • 33645861080 scopus 로고    scopus 로고
    • Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
    • CHARISMA Investigators
    • Bhatt DL, et al.; CHARISMA Investigators (2006) Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354:1706-1717.
    • (2006) N Engl J Med , vol.354 , pp. 1706-1717
    • Bhatt, D.L.1
  • 3
    • 85058720552 scopus 로고    scopus 로고
    • The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: Study design and rationale
    • TRA*CER Executive and Steering Committees
    • TRA*CER Executive and Steering Committees (2009) The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: Study design and rationale. Am Heart J 158:327-334.e4.
    • (2009) Am Heart J , vol.158
  • 4
    • 68949156886 scopus 로고    scopus 로고
    • Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial
    • Morrow DA, et al. (2009) Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: Design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial. Am Heart J 158:335-341.e3.
    • (2009) Am Heart J , vol.158
    • Morrow, D.A.1
  • 5
    • 0014191175 scopus 로고
    • Actions of thrombin and other coagulant and proteolytic enzymes on blood platelets
    • Davey MG, Lüscher EF (1967) Actions of thrombin and other coagulant and proteolytic enzymes on blood platelets. Nature 216:857-858.
    • (1967) Nature , vol.216 , pp. 857-858
    • Davey, M.G.1    Lüscher, E.F.2
  • 6
    • 0026035523 scopus 로고
    • Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
    • Vu TK, Hung DT, Wheaton VI, Coughlin SR (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068.
    • (1991) Cell , vol.64 , pp. 1057-1068
    • Vu, T.K.1    Hung, D.T.2    Wheaton, V.I.3    Coughlin, S.R.4
  • 8
    • 0042703242 scopus 로고    scopus 로고
    • Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis
    • Conley PB, Delaney SM (2003) Scientific and therapeutic insights into the role of the platelet P2Y12 receptor in thrombosis. Curr Opin Hematol 10:333-338.
    • (2003) Curr Opin Hematol , vol.10 , pp. 333-338
    • Conley, P.B.1    Delaney, S.M.2
  • 10
    • 36148983750 scopus 로고    scopus 로고
    • Prasugrel versus clopidogrel in patients with acute coronary syndromes
    • TRITON-TIMI 38 Investigators
    • Wiviott SD, et al.; TRITON-TIMI 38 Investigators (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001-2015.
    • (2007) N Engl J Med , vol.357 , pp. 2001-2015
    • Wiviott, S.D.1
  • 11
    • 0022180156 scopus 로고
    • Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation
    • Shattil SJ, Hoxie JA, Cunningham M, Brass LF (1985) Changes in the platelet membrane glycoprotein IIb.IIIa complex during platelet activation. J Biol Chem 260:11107-11114.
    • (1985) J Biol Chem , vol.260 , pp. 11107-11114
    • Shattil, S.J.1    Hoxie, J.A.2    Cunningham, M.3    Brass, L.F.4
  • 12
    • 0024357563 scopus 로고
    • PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes
    • Larsen E, et al. (1989) PADGEM protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 59:305-312.
    • (1989) Cell , vol.59 , pp. 305-312
    • Larsen, E.1
  • 14
    • 0034611727 scopus 로고    scopus 로고
    • PAR3 is a cofactor for PAR4 activation by thrombin
    • Nakanishi-Matsui M, et al. (2000) PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404:609-613.
    • (2000) Nature , vol.404 , pp. 609-613
    • Nakanishi-Matsui, M.1
  • 15
    • 0035817822 scopus 로고    scopus 로고
    • Role of thrombin signalling in platelets in haemostasis and thrombosis
    • DOI 10.1038/35092573
    • Sambrano GR, Weiss EJ, Zheng YW, Huang W, Coughlin SR (2001) Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature 413:74-78. (Pubitemid 32843490)
    • (2001) Nature , vol.413 , Issue.6851 , pp. 74-78
    • Sambrano, G.R.1    Weiss, E.J.2    Zheng, Y.-W.3    Huang, W.4    Coughlin, S.R.5
  • 16
    • 44949114152 scopus 로고    scopus 로고
    • Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity
    • Chackalamannil S, et al. (2008) Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity. J Med Chem 51:3061-3064.
    • (2008) J Med Chem , vol.51 , pp. 3061-3064
    • Chackalamannil, S.1
  • 17
    • 0017672833 scopus 로고
    • Interrelations of platelet aggregation and secretion
    • Charo IF, Feinman RD, Detwiler TC (1977) Interrelations of platelet aggregation and secretion. J Clin Invest 60:866-873.
    • (1977) J Clin Invest , vol.60 , pp. 866-873
    • Charo, I.F.1    Feinman, R.D.2    Detwiler, T.C.3
  • 18
    • 0034978187 scopus 로고    scopus 로고
    • Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs
    • Foster CJ, et al. (2001) Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest 107:1591-1598.
    • (2001) J Clin Invest , vol.107 , pp. 1591-1598
    • Foster, C.J.1
  • 19
    • 60849138406 scopus 로고    scopus 로고
    • Functional variability of platelet response to clopidogrel correlates with P2Y(12) receptor occupancy
    • Bal Dit Sollier C, Berge N, Boval B, Hovsepian L, Drouet L (2009) Functional variability of platelet response to clopidogrel correlates with P2Y(12) receptor occupancy. Thromb Haemost 101:116-122.
    • (2009) Thromb Haemost , vol.101 , pp. 116-122
    • Bal Dit Sollier, C.1    Berge, N.2    Boval, B.3    Hovsepian, L.4    Drouet, L.5
  • 20
    • 74649085430 scopus 로고    scopus 로고
    • Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): A randomised double-blind study
    • PLATelet inhibition and patient Outcomes investigators
    • Cannon CP, et al.; PLATelet inhibition and patient Outcomes investigators (2010) Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): A randomised double-blind study. Lancet 375:283-293.
    • (2010) Lancet , vol.375 , pp. 283-293
    • Cannon, C.P.1
  • 21
    • 70149101223 scopus 로고    scopus 로고
    • Ticagrelor versus clopidogrel in patients with acute coronary syndromes
    • PLATO Investigators
    • Wallentin L, et al.; PLATO Investigators (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045-1057.
    • (2009) N Engl J Med , vol.361 , pp. 1045-1057
    • Wallentin, L.1
  • 22
    • 0345707537 scopus 로고    scopus 로고
    • Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis
    • André P, et al. (2003) Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis. Circulation 108:2697-2703.
    • (2003) Circulation , vol.108 , pp. 2697-2703
    • André, P.1
  • 23
    • 0032842812 scopus 로고    scopus 로고
    • Mechanisms of progression in native coronary artery disease: Role of healed plaque disruption
    • Mann J, Davies MJ (1999) Mechanisms of progression in native coronary artery disease: Role of healed plaque disruption. Heart 82:265-268.
    • (1999) Heart , vol.82 , pp. 265-268
    • Mann, J.1    Davies, M.J.2
  • 24
    • 0035916310 scopus 로고    scopus 로고
    • Healed plaque ruptures and sudden coronary death: Evidence that subclinical rupture has a role in plaque progression
    • Burke AP, et al. (2001) Healed plaque ruptures and sudden coronary death: Evidence that subclinical rupture has a role in plaque progression. Circulation 103:934-940.
    • (2001) Circulation , vol.103 , pp. 934-940
    • Burke, A.P.1
  • 26
    • 9644291604 scopus 로고    scopus 로고
    • An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research
    • DOI 10.1016/j.thromres.2004.07.009, PII S0049384804004104
    • Wang X, Xu L (2005) An optimized murine model of ferric chloride-induced arterial thrombosis for thrombosis research. Thromb Res 115:95-100. (Pubitemid 39572761)
    • (2005) Thrombosis Research , vol.115 , Issue.1-2 , pp. 95-100
    • Wang, X.1    Xu, L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.